Hospital Pharmacy - October 2019 - 326
326
Hospital Pharmacy 54(5)
Discussion
Table 2. Prophylactic Antibiotic Use Around Surgical
Procedures in Hospitals A and B, Expressed as DDD.
Antibiotic
Hospital A
Amphenicols
Thiamphenicol
-
Penicillins with extended spectrum
Amoxicillin
0.5
Penicillins combined with beta-lactamase inhibitors
Ampicillin and enzyme inhibitor
7.3
Amoxicillin and enzyme inhibitor
17.8
Cephalosporins, first generation
Cefazolin
7.0
Cefadroxil
4.1
Cephalosporins, second generation
Cefuroxime
27.9
Cefaclor
0.2
Cephalosporins, third generation
Cefotaxime
6.8
Ceftazidime
21.3
Ceftriaxone
285.9
Ceftizoxime
25.5
Cefixime
42.5
Cefoperazone, combinations
10.0
Cephalosporins, fourth generation
Cefepime
1.0
Cefpirome
7.3
Carbapenems
Meropenem
28.0
Imipenem and enzyme inhibitor
-
Macrolides
Azithromycin
1.7
Lincosamides
Clindamycin
-
Aminoglycosides
Gentamicin
0.3
Kanamycin
-
Amikacin
1.5
Fluoroquinolones
Ciprofloxacin
5.0
Levofloxacin
5.0
Imidazole derivatives
Metronidazole
1.7
Other antibiotics
Fosfomycin
0.4
Total DDD
508.5
DDD per patient
1.5
DDD per 100 bed days
-
Hospital B
2.5
-
8.7
44.0
25.5
5.8
5.2
-
1.6
7.1
97.8
0.3
59.3
17.3
12.5
0.3
53.0
19.0
0.8
3.3
9.9
0.5
77.3
18.8
33.5
63.3
-
567.0
1.7
30.4
Note. DDD = defined daily doses.
than of the average patient (5.4 days). Their diagnoses were
noninsulin-dependent diabetes mellitus with neurological
complication, acute peritonitis, rectal cancer, focal brain
injury, and benign neoplasm of the ovary.
This study clearly shows that the volume of prophylactic
antibiotic use is large, with more than 80% using two or
more antibiotics, and that a wide variety of different antibiotics including in most cases third generation cephalosporins
was applied in the study hospitals.
The choice of an antibiotic should be based on its antibacterial spectrum and the indication. The main bacteria causing
surgical site infections after clean procedures are the grampositive S. aureus and coagulase-negative staphylococci (eg,
Staphylococcus epidermidis) which are common species of
the skin flora. In clean-contaminated procedures, including
abdominal surgery and heart, kidney, and liver transplantations, bacteria that cause surgical site infections are similar to
those at the skin flora in a clean procedure, plus gramnegative rods, and enterococci. According to the guideline
published by IMOH7, cefazolin, a first generation cephalosporin, is applied to prevent such infections. Third generation cephalosporins such as the frequently used ceftriaxone
and cefixime in hospitals A and B are not the prophylactic
antibiotics of choice here. Cefixime was used as a ceftriaxone substitute when switching from an intravenous to an oral
antibiotic. Besides staphylococci and enterococci, ureaplasma and anaerobic bacteria are common organisms isolated from wound infections. Therefore, azithromycin or
metronidazole may be added to suppress these organisms.
Furthermore, the addition of vancomycin to cefazolin is recommended when MRSA is a frequent cause of infection.15,16
For patients allergic to beta-lactam, the recommended prophylactic antibiotics are gentamicin, fluoroquinolone,
clindamycin, or vancomycin.6
Meropenem and amikacin, both frequently applied, especially in hospital B (Table 2), are highly potent broad spectrum antibiotics used as alternatives if the bacteria are already
unsusceptible to cephalosporins and gentamicin. Ceftriaxone,
amikacin, and meropenem are not recommended for specific
gram-positive skin flora. Therefore, the use of ceftriaxone
should be limited and only be applied based on results from
an antibiotics sensitivity test showing the presence of gramnegative bacteria.
The DDD is used for benchmarking between hospitals.14
Overall, in this study, the antibiotic use was 30 DDD per
100BD meaning that on average, there were 0.3 WHO's
DDD per patient per day or 30 WHO's DDD for 100 patients
per day. This means that 30% of the patients received a DDD
of a prophylactic antibiotic per day.
The antibiotic use in hospitals A and B in 2016, with
higher preference for cephalosporins than for penicillins,
was different from the antibiotic use in two other hospitals in
Indonesia in 2005,17 where penicillins were preferred over
cephalosporins. Comparable DDD-100BD were reported for
the Isparta State Hospital in Turkey in 2013, a secondary
health care facility with 372 beds, with 49.1 DDD-100BD;
<2 DDD per patient.18 It was lower than two hospitals in
Hospital Pharmacy - October 2019
Table of Contents for the Digital Edition of Hospital Pharmacy - October 2019
TOC/Verso
Disrespectful Behavior in Health System Pharmacy Practice: Consequences and Next Steps
The Orphan Drug Act: An Appropriate Approval Pathway for Treatments of Rare Diseases?
Significant Published Articles for Pharmacy Nutrition Support Practice in 2018
Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection
Evaluation of a Hospital Pharmacist Annual Competency Program
A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs
Impact of an Advanced Pharmacy Practice Experience Student-Run “Meds 2 Beds” and Discharge Counseling Program on Quality of Care
A Retrospective Surveillance of the Antibiotics Prophylactic Use of Surgical Procedures in Private Hospitals in Indonesia
Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures: A New Look at an Old Drug
The Impact of an Automated Dispensing System for Supplying Narcotics in a Surgical Unit: The Experience of the National Cancer Institute Foundation of Milan
Hospital Pharmacy - October 2019 - Cover1
Hospital Pharmacy - October 2019 - Cover2
Hospital Pharmacy - October 2019 - 277
Hospital Pharmacy - October 2019 - TOC/Verso
Hospital Pharmacy - October 2019 - 279
Hospital Pharmacy - October 2019 - Disrespectful Behavior in Health System Pharmacy Practice: Consequences and Next Steps
Hospital Pharmacy - October 2019 - 281
Hospital Pharmacy - October 2019 - 282
Hospital Pharmacy - October 2019 - The Orphan Drug Act: An Appropriate Approval Pathway for Treatments of Rare Diseases?
Hospital Pharmacy - October 2019 - 284
Hospital Pharmacy - October 2019 - Significant Published Articles for Pharmacy Nutrition Support Practice in 2018
Hospital Pharmacy - October 2019 - 286
Hospital Pharmacy - October 2019 - 287
Hospital Pharmacy - October 2019 - 288
Hospital Pharmacy - October 2019 - 289
Hospital Pharmacy - October 2019 - 290
Hospital Pharmacy - October 2019 - 291
Hospital Pharmacy - October 2019 - 292
Hospital Pharmacy - October 2019 - 293
Hospital Pharmacy - October 2019 - Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection
Hospital Pharmacy - October 2019 - 295
Hospital Pharmacy - October 2019 - 296
Hospital Pharmacy - October 2019 - 297
Hospital Pharmacy - October 2019 - 298
Hospital Pharmacy - October 2019 - 299
Hospital Pharmacy - October 2019 - Evaluation of a Hospital Pharmacist Annual Competency Program
Hospital Pharmacy - October 2019 - 301
Hospital Pharmacy - October 2019 - 302
Hospital Pharmacy - October 2019 - 303
Hospital Pharmacy - October 2019 - 304
Hospital Pharmacy - October 2019 - 305
Hospital Pharmacy - October 2019 - 306
Hospital Pharmacy - October 2019 - 307
Hospital Pharmacy - October 2019 - 308
Hospital Pharmacy - October 2019 - A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs
Hospital Pharmacy - October 2019 - 310
Hospital Pharmacy - October 2019 - 311
Hospital Pharmacy - October 2019 - 312
Hospital Pharmacy - October 2019 - 313
Hospital Pharmacy - October 2019 - Impact of an Advanced Pharmacy Practice Experience Student-Run “Meds 2 Beds” and Discharge Counseling Program on Quality of Care
Hospital Pharmacy - October 2019 - 315
Hospital Pharmacy - October 2019 - 316
Hospital Pharmacy - October 2019 - 317
Hospital Pharmacy - October 2019 - 318
Hospital Pharmacy - October 2019 - 319
Hospital Pharmacy - October 2019 - 320
Hospital Pharmacy - October 2019 - 321
Hospital Pharmacy - October 2019 - 322
Hospital Pharmacy - October 2019 - A Retrospective Surveillance of the Antibiotics Prophylactic Use of Surgical Procedures in Private Hospitals in Indonesia
Hospital Pharmacy - October 2019 - 324
Hospital Pharmacy - October 2019 - 325
Hospital Pharmacy - October 2019 - 326
Hospital Pharmacy - October 2019 - 327
Hospital Pharmacy - October 2019 - 328
Hospital Pharmacy - October 2019 - 329
Hospital Pharmacy - October 2019 - Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures: A New Look at an Old Drug
Hospital Pharmacy - October 2019 - 331
Hospital Pharmacy - October 2019 - 332
Hospital Pharmacy - October 2019 - 333
Hospital Pharmacy - October 2019 - 334
Hospital Pharmacy - October 2019 - The Impact of an Automated Dispensing System for Supplying Narcotics in a Surgical Unit: The Experience of the National Cancer Institute Foundation of Milan
Hospital Pharmacy - October 2019 - 336
Hospital Pharmacy - October 2019 - 337
Hospital Pharmacy - October 2019 - 338
Hospital Pharmacy - October 2019 - 339
Hospital Pharmacy - October 2019 - 340
Hospital Pharmacy - October 2019 - 341
Hospital Pharmacy - October 2019 - 342
Hospital Pharmacy - October 2019 - 343
Hospital Pharmacy - October 2019 - 344
Hospital Pharmacy - October 2019 - Cover3
Hospital Pharmacy - October 2019 - Cover4
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com